A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2002
08/29/2002	CA2442293A1 Zinc finger binding domains for nucleotide sequence ann
08/29/2002	CA2440197A1 Synthetic vaccines comprising polyhydroxypolymer carriers
08/29/2002	CA2439193A1 Casoase 3 inhibitors
08/29/2002	CA2438805A1 Fluoro oxindole derivatives as modulators of kcnq potassium channels
08/29/2002	CA2438750A1 Aminoglycoside treatment for lysosomal storage diseases
08/29/2002	CA2438711A1 Tryptase inhibitors
08/29/2002	CA2438685A1 Tryptase inhibitors
08/29/2002	CA2438682A1 Antibodies that bind both bcma and taci
08/29/2002	CA2438628A1 Artificial proteins with reduced immunogenicity
08/29/2002	CA2438598A1 Epothilone derivatives for the treatment of refractory tumors
08/29/2002	CA2438518A1 Method of treating neurological diseases
08/29/2002	CA2438513A1 Modified anti-egfr antibodies with reduced immunogenicity
08/29/2002	CA2438367A1 Thiophene substituted amine derivatives as glyt-1 inhibitors
08/29/2002	CA2438318A1 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
08/29/2002	CA2438316A1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
08/29/2002	CA2438312A1 Anthrone derivatives and their use as jnk inhibitors
08/29/2002	CA2438241A1 Medicinal compositions comprising diclofenac and ornoprostil
08/29/2002	CA2438231A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
08/29/2002	CA2437989A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
08/29/2002	CA2437977A1 Phenethanolamine derivatives for treatment of respiratory diseases
08/29/2002	CA2437529A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
08/29/2002	CA2435177A1 2-arylamino-pyrimidines for the treatment of gsk3-related disorders
08/29/2002	CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same
08/29/2002	CA2434648A1 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
08/29/2002	CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/29/2002	CA2426659A1 Method for treatment of tumors using combination therapy
08/29/2002	CA2411973A1 New phenylpiperazines
08/28/2002	EP1234834A1 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
08/28/2002	EP1234816A1 Scyphostatin analogues as SMase inhibitors
08/28/2002	EP1234582A1 Concomitant drugs for treating glaucoma
08/28/2002	EP1234577A1 Radioprotecting agent
08/28/2002	EP1234574A1 Hair growth stimulant
08/28/2002	EP1234185A2 Pin1 as a marker for abnormal cell growth
08/28/2002	EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies
08/28/2002	EP1233985A1 Collagen
08/28/2002	EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies
08/28/2002	EP1233975A1 29 human secreted proteins
08/28/2002	EP1233973A1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives
08/28/2002	EP1233968A2 Transition metal-cyclopentadienyl-tropane conjugates
08/28/2002	EP1233965A1 Isoquinoline and quinazoline derivatives for the treatment of cns disorders
08/28/2002	EP1233964A1 New use and novel n-azabicyclo-amide derivatives
08/28/2002	EP1233960A2 Polymorphic salt of an anti-migraine drug
08/28/2002	EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
08/28/2002	EP1233958A1 Inhibitors of histone deacetylase
08/28/2002	EP1233957A1 Novel amidine derivatives, preparation and use thereof as medicines
08/28/2002	EP1233953A1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same
08/28/2002	EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
08/28/2002	EP1233950A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
08/28/2002	EP1233948A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
08/28/2002	EP1233943A2 Ionizable indolinone derivatives and their use as ptk ligands
08/28/2002	EP1233815A1 Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension
08/28/2002	EP1233787A1 Product inhibiting transduction of g heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment
08/28/2002	EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
08/28/2002	EP1233778A1 Stanniocalcin proteins and nucleic acids and methods based thereon
08/28/2002	EP1233777A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies
08/28/2002	EP1233774A1 Urotensin-ii analogs
08/28/2002	EP1233773A1 Mixture of pomegranate seed oil and juice products
08/28/2002	EP1233771A1 Protease inhibitors
08/28/2002	EP1233770A2 Phosphonate compounds
08/28/2002	EP1233769A1 Novel compounds
08/28/2002	EP1233766A1 Use of synergistic combinations of a nk 1? receptor antagonist and a gaba analog in psychiatric disorders
08/28/2002	EP1233765A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-$g(d) ACTIVITY
08/28/2002	EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
08/28/2002	EP1140898B1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
08/28/2002	EP1082114B1 Hydroxyomeprazole compositions and uses
08/28/2002	EP1071702B1 Fatty acid derivatives of bile acids and bile acid derivatives
08/28/2002	EP1040106B1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
08/28/2002	EP0988300B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
08/28/2002	EP0973731B1 Hydroxamic acid derivatives
08/28/2002	EP0918777B1 SELECTED DERIVATIVES OF K-252a
08/28/2002	EP0892804B1 Isoxazolidine derivatives
08/28/2002	EP0848696B1 2,4-pentadienoic acid derivatives having retinoid-like biological activity
08/28/2002	EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease
08/28/2002	EP0800387B1 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours
08/28/2002	EP0741741B1 Modified oligonucleotides
08/28/2002	CN1366519A Phenoxazine compounds, its pharmaceutical compositions and medical use
08/28/2002	CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor
08/28/2002	CN1366461A Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as active ingredient
08/28/2002	CN1366460A Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as active ingredient
08/28/2002	CN1366459A Preventive or therapeutic drugs for various eosinophilia-realated diseases containing chymase inhibitors as active ingredient
08/28/2002	CN1366062A Recombination carrier and treating composition used in insulin dependent diabetes gene curing
08/28/2002	CN1365830A Capsule 'Linkangning'
08/28/2002	CN1365812A Nano medicine 'Hongling' and its preparing process
08/28/2002	CN1365811A Nano medicine 'Huixiang Juhe' and its preparing process
08/28/2002	CN1365810A Nano medicine 'Guishao Dihuang' and its preparing process
08/28/2002	CN1365782A Nano medicine 'Rukuaixiao' and its preparing process
08/28/2002	CN1365781A Nano medicine 'Ruyi Jinhuang' and its preparing process
08/28/2002	CN1365779A Nano medicine 'Qinge' and its preparing process
08/28/2002	CN1365778A Nano medicine 'Qinlian' and its preparing process
08/28/2002	CN1365776A Nano medicine 'Pinggan Shuluo' and its preparing process
08/28/2002	CN1365772A Nano medicine 'Niuhuang Baolong' and its preparing process
08/28/2002	CN1365770A Nano medicine 'Miaoji' and its preparing process
08/28/2002	CN1365767A Nano cyperus tuber medicine and its preparing process
08/28/2002	CN1365743A Nano medicine 'Keyin' and its preparing process
08/28/2002	CN1365740A Nano medicine 'Jufang' and its preparing process
08/28/2002	CN1365738A Nano tiger bone-papaya medicine and its preparing process
08/28/2002	CN1365727A Nano cinammon twigs medicine and its preparing process
08/28/2002	CN1365720A Nano 25-component pearl medicine and its preparing process
08/28/2002	CN1365702A Nano medicine for treating infantile convulsion and its preparing process
08/28/2002	CN1365700A Nano 25-component coral medicine and its preparing process

1 ... 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 ... 1564